Synosis, a South San Francisco company developing treatments for neurological disorders, said it has raised $32.5 million and has entered a partnership with Roche.

Synosis, which was spun out of an incubator EuroVentures (owned by Versant Ventures), raised its cash from from Versant Ventures, Abingworth Management, 5AM Ventures and Novo A/S. The Roche partnership could lead to development of treatments for schizophrenia, cognitive disorders, Parkinson’s, drug dependency and pain, the company said.

More details here.